Avatrombopag

• Description:

  Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  649.65

• Molecular Formula:

  C29H34Cl2N6O3S2

• Notes:

  Research use only, not for human use.

• Receptor:

  TPO

• CAS Number:

  570406-98-3